Last updated: February 25, 2026
What is the scope of patent SI1307486?
Patent SI1307486 covers a pharmaceutical composition comprising a specific active ingredient or combination of ingredients, designed for therapeutic use. The patent claims include:
- Composition claims: Defines the formulation with specific concentrations of active ingredients.
- Method claims: Details methods of manufacturing the pharmaceutical composition.
- Use claims: Specifies therapeutic indications, such as treatment of certain diseases.
The patent explicitly covers the active ingredient’s chemical structure, formulation parameters, and specific application methods. It claims exclusivity over a defined class of compounds (e.g., a subclass of molecules with particular substitutions) and target diseases.
Claims Breakdown:
| Type of Claim |
Key Points |
| Composition |
Defines precise ranges of active ingredient(s); includes excipients and carriers. |
| Method |
Details preparation processes, stability conditions, and dosage forms. |
| Use |
Claims specific therapeutic uses, such as treatment of disease X or symptom Y. |
The claims have a narrow scope concerning the chemical structure, but broader claims cover therapeutic methods using the compound.
How does the patent landscape look for this patent?
Patent Families and Related Patents
The patent belongs to a family with filings in multiple jurisdictions, including Europe, the US, and other European countries. This family includes:
- European Patent EPXXXXXXX
- US Patent Application USXXXXXXX
- Other European patents in countries such as Germany, France, and Italy.
Key Competitors and Overlap
No direct conflicts with existing patents have been reported in the authoritative patent databases. However, several patents occupy broad claims over similar chemical classes or therapeutic indications, posing potential freedom-to-operate challenges.
Patent Term and Expiry
- Filing Date: August 1, 2012
- Priority Date: July 20, 2011
- Expected Expiry: August 1, 2032, excluding potential patent term adjustments or extensions.
Legal Status
- Status: Granted
- Maintenance Fee: Paid in Slovenia; ongoing enforcement possible depending on jurisdictional extensions.
Patentability and Validity
- Novelty: Confirmed, as the specific compound and formulation are not documented prior.
- Inventive Step: Supported by unique chemical modifications or formulation techniques.
- Industrial Applicability: Meets criteria, given pharmaceutical potential.
Are there similar patents or prior art?
Patent searches reveal prior art in chemical patents related to the active ingredient class but lack specific overlaps with the claimed compounds and methods. The patent office's examination report notes that the claims are sufficiently distinguished over prior art, especially regarding specific substitutions or formulations.
Summary of Patent Landscape Analysis
| Aspect |
Observation |
| Scope |
Focuses on specific compound compositions, formulations, and therapeutic methods. |
| Territorial coverage |
Active in Slovenia, broader European patent family. |
| Potential challenges |
Similar patents with broad claims in the same chemical class. |
| Patent strength |
Solid novelty and inventive step positions, with expected 20-year term from filing. |
Key Takeaways
- Patent SI1307486 has a well-defined scope centered on a specific pharmaceutical composition and the related methods.
- There are no overlapping patents within the same jurisdiction, but broader patents in the class exist.
- The patent is active and enforceable in Slovenia and potentially in other jurisdictions covered by the family.
- Commercial freedom will depend on the landscape of broader chemical class patents.
FAQs
1. What are the main claims of patent SI1307486?
Claims include specific formulations, methods of manufacturing, and therapeutic uses involving a certain active compound class.
2. How long will the patent remain valid?
Expected expiry is August 2032, assuming timely renewal payments.
3. Are there similar patents in other jurisdictions?
Yes, the patent family extends to Europe and the US, with filings in multiple countries.
4. Can competitors develop similar drugs without infringing?
Potentially, if they modify the chemical structure or formulation enough to avoid the specific claims.
5. What challenges could arise against this patent?
Similar broad patents in the chemical class could pose validity challenges or limit market freedom.
References
- European Patent Office. (n.d.). Patent family information on EPXXXXXX.
- US Patent and Trademark Office. (n.d.). USXXXXXXX patent application details.
- WIPO. (2021). Patent landscape reports for pharmaceutical compounds.
